Research Analysts’ Recent Ratings Changes for National Health Investors (NHI)

Several brokerages have updated their recommendations and price targets on shares of National Health Investors (NYSE: NHI) in the last few weeks:

• 9/10/2026 – National Health Investors is now covered by Huntington. They set an “outperform” rating and a $79.00 price target on the stock.
• 9/9/2026 – National Health Investors was given a new $79.00 price target by National Bank Financial.
• 9/9/2026 – National Health Investors had its “buy (b-)” rating reaffirmed by Weiss Ratings.
• 9/2/2026 – National Health Investors had its price target lowered by Truist Financial Corporation from $81.00 to $80.00. They now have a “buy” rating on the stock.
• 9/1/2026 – National Health Investors had its price target lowered by Wells Fargo & Company from $79.00 to $78.00. They now have an “equal weight” rating on the stock.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.2%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio is presently 106.36%.

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.